Apax Funds has entered into an agreement to acquire Rodenstock Group, a leading manufacturer of premium ophthalmic lenses, to enhance its growth through innovation and digital transformation.

Target Company Overview

Apax Funds has announced an agreement to acquire Rodenstock Group, a well-established leader in the production of premium ophthalmic lenses, from Compass Partners. Founded in 1877 and headquartered in Munich, Germany, Rodenstock has been at the forefront of innovative lens solutions for over 140 years. The company employs approximately 4,900 people globally and operates with sales subsidiaries and distribution partners across more than 85 countries. Rodenstock has developed a robust pipeline of innovations, prominently featuring its DNEye Pro technology, which uniquely measures the shape and size of individual eyes to produce personalized eyeglass lenses known as Biometric Intelligent Glasses (B.I.G. VISION™). Additionally, the company markets eyewear under the renowned Rodenstock and Porsche Design brands.

Industry Overview in Germany

The ophthalmic lens industry in Germany has experienced notable growth, largely driven by advances in technology and an increasing demand for personalized vision solutions. As a global leader in the medical technology and healthcare sectors, Germany is home to highly innovative companies that contribute to shaping the future of vision care. The country's emphasis on research and development, coupled with stringent quality standards, ensures that German ophthalmic products are recognized for their excellence and reliability.

Moreover, the shift towards digital health solutions has further fueled growth within the industry, with more consumers seeking customizable options that cater to their specific vision nee